Dr. Sibley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Page Mill Road
Palo Alto, CA 94301
Summary
- Late stage drug development with broad clinical trial experience in academics, the public sector and biopharma
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2005 - 2009
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2001 - 2005- Northwestern University The Feinberg School of MedicineClass of 2001
Certifications & Licensure
OR State Medical License 2013 - 2019
MD State Medical License Active through 2013
Clinical Trials
- A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism Start of enrollment: 2019 Aug 27
- A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism Start of enrollment: 2021 Feb 16
- High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPalopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, Noriko Makita, Yasuo Imanishi
Advances in Therapy. 2024-06-01 - 18 citationsEfficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes, Dolores M Shoback
Journal of Bone and Mineral Research. 2023-01-01 - 2 citationsCoronary CT Angiography and Carotid MRI Improve Phenotyping of Disease Extent Compared with ACC/AHA Risk Score Alone.Ashley Chorath, Younhee Choi, Evrim B. Turkbey, Mark A. Ahlman, Christopher T. Sibley
Radiology. Cardiothoracic Imaging. 2020-02-27
Authored Content
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
Research History
- Staff Clinician, NIHNIH Clinical Center, Nation Institute of Biomedical Imaging and Bioengineering2009 - 2013
Professional Memberships
- Member
Industry Relationships
- Medical Director, Clinical Development, Ascendis Pharma N/ATransCon PTH development program2020 - Present
- Principal Consultant, Great Point Health2017 - 2020
- Clinical Director, Merck & Co.2016 - 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
